Trichomonas Vaginalis and SLPI Mucosal Defenses
阴道毛滴虫和 SLPI 粘膜防御
基本信息
- 批准号:6345955
- 负责人:
- 金额:$ 3.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2001-08-31
- 项目状态:已结题
- 来源:
- 关键词:Chlamydia trachomatis Lactobacillus Neisseria gonorrhoeae SDS polyacrylamide gel electrophoresis Trichomonas vaginalis adolescence (12-20) bacterial proteins clinical research cooperative study cysteine endopeptidases enzyme activity enzyme inhibitors enzyme linked immunosorbent assay female genital secretion host organism interaction human subject ion exchange chromatography iron lactoferrin mucosal immunity protein sequence serine proteinases sexually transmitted diseases transferrin vagina western blottings
项目摘要
TRICHOMONAS VAGINALIS AND SLPI MUCOSAL DEFENSES. Deborah Draper, Ph.D. The long term objectives of this grant are to understand the mucosal environment of the health female genital tract in terms of its non-immune protective mechanisms against Trichomonas vaginalis and other STDs including HIV infection, and the inflammatory response. Experiments will focus on protective mechanisms provided by secretory leukocyte protease inhibitor (SLPI), a predominant serine protease inhibitor found on the vaginal epithelium and determine the deleterious effects of T. vaginalis proteases (TVPs) on SLPI function. We hypothesize that Trichomonas vaginalis (TV) cysteine proteases cleave to: 1) determine the normal antimicrobial function of SLPI against STD organisms including Trichomonas vaginalis (TV), Neisseria gonorrhoeae (GC), and Chlamydia trachomatis (CT). 2) determine the antimicrobial function of SLPI under different broth growth and metabolic conditions of TV including aerobic and anaerobic growth; different concentrations of free iron, and human transferrin and lactoferrin; and in the presence and absence of cysteine protease inhibitor, E-64. 3) isolate and characterize the specific TVP activity which causes the degradation of SLPI. Three TVPs (220, 92 and 68 kDa) will be isolated by ion exchange chromatography of induction supernatants and tested for their individual degradative effects on SLPI by SDS-PAGE and Western blot. 4) Resulting peptide fragments will be sequenced by gas phase microsequencing. The TVP cleavage sites and peptides will be mapped to known sequence data and functional domains. 5) Residual antimicrobic function of peptides will be tested, 6) We will determine SLPI levels in normal and infected secretions from the adolescent female genital tract. Adolescent girls, ages 14-19, will have vaginal fluid samples taken and SLPI levels determined by ELISA assay. These patients will be followed longitudinally over a year and SLPI levels compared to Lactobacillus crispatus carriage rates. The mechanisms elucidated here will be relevant to our understanding of native vaginal mechanisms of homeostasis and during infection with simple or complicated genital tract disease. These findings may also be relevant to mechanisms of infection of other mucosal STD pathogens including HIV infection, and other parasitic diseases.
阴道毛滴虫与SLPI粘膜防御Deborah德雷珀博士这项赠款的长期目标是了解健康女性生殖道的粘膜环境,了解其对阴道毛滴虫和其他性病(包括艾滋病毒感染)的非免疫保护机制以及炎症反应。实验将集中在分泌性白细胞蛋白酶抑制剂(SLPI)提供的保护机制,一种主要的丝氨酸蛋白酶抑制剂,发现在阴道上皮细胞和确定T。迷走蛋白酶(TVP)对SLPI功能的影响。我们假设阴道毛滴虫(TV)半胱氨酸蛋白酶切割:1)确定SLPI对STD微生物(包括阴道毛滴虫(TV)、淋病奈瑟菌(GC)和沙眼衣原体(CT))的正常抗菌功能。2)确定SLPI在TV的不同肉汤生长和代谢条件下的抗微生物功能,包括需氧和厌氧生长;不同浓度的游离铁、人转铁蛋白和乳铁蛋白;以及在存在和不存在半胱氨酸蛋白酶抑制剂E-64的情况下。3)分离并表征导致SLPI降解的特异性TVP活性。将通过诱导上清液的离子交换层析分离三种TVP(220、92和68 kDa),并通过SDS-PAGE和蛋白质印迹测试其对SLPI的单独降解作用。4)将通过气相微测序对所得肽片段进行测序。将TVP切割位点和肽映射到已知的序列数据和功能结构域。5)将测试肽的残余抗微生物功能。6)我们将测定来自青春期女性生殖道的正常和感染分泌物中的SLPI水平。将对14-19岁的青春期女孩进行阴道液采样,并通过ELISA测定确定SLPI水平。这些患者将纵向随访一年以上,并将SLPI水平与卷曲乳杆菌携带率进行比较。本文阐明的机制将有助于我们理解阴道内稳态的天然机制以及简单或复杂生殖道疾病感染期间的阴道内稳态机制。这些发现也可能与其他粘膜性病病原体(包括HIV感染)和其他寄生虫病的感染机制有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBORAH L DRAPER其他文献
DEBORAH L DRAPER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBORAH L DRAPER', 18)}}的其他基金
TRICHOMONAS VAGINALIS AND SLPI MUCOSAL DEFENSES
阴道毛滴虫和 SLPI 粘膜防御
- 批准号:
6654011 - 财政年份:2002
- 资助金额:
$ 3.57万 - 项目类别:
TRICHOMONAS VAGINALIS AND SLPI MUCOSAL DEFENSES
阴道毛滴虫和 SLPI 粘膜防御
- 批准号:
6340747 - 财政年份:2000
- 资助金额:
$ 3.57万 - 项目类别:
TRICHOMONAS VAGINALIS AND SLPI MUCOSAL DEFENSES
阴道毛滴虫和 SLPI 粘膜防御
- 批准号:
6208418 - 财政年份:1999
- 资助金额:
$ 3.57万 - 项目类别:
Trichomonas Vaginalis and SLPI Mucosal Defenses
阴道毛滴虫和 SLPI 粘膜防御
- 批准号:
6221882 - 财政年份:1999
- 资助金额:
$ 3.57万 - 项目类别:
相似国自然基金
瘤内细菌 Lactobacillus iners 通过
eIF4A2 乳酸化介导肿瘤相关巨噬细胞极
化诱导膀胱癌免疫化疗抵抗的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
肠道菌群Lactobacillus来源的吲哚-3-
甲醛对绝经后骨量丢失的保护机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
Lactobacillus reuteri调控FTO/CMPK2/NLRP3信号轴介导炎症反应治疗5-FU诱导的口腔粘膜炎的作用研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
葛根交泰丸调控Lactobacillus介导胆汁酸“肠-肝轴”途径治疗2型糖尿病的机制研究
- 批准号:82305009
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
草苁蓉介导的肠道Lactobacillus reuteri菌通过长链脂肪酸调控糖脂代谢改善2型糖尿病的作用机制
- 批准号:32260026
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
Lactobacillus plantarum CQPC05通过细胞凋亡通路干预结直肠癌的效果
- 批准号:
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于肠道菌群-免疫轴解析Lactobacillus murinus 0516抗鸡传染性支气管炎病毒感染的机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
猪肠道细菌Lactobacillus gasseri LA39调控胆汁酸代谢的研究
- 批准号:
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
荔枝黄酮QRR与原花青素A2协同增殖肠道Akkermansia和Lactobacillus菌保护肠粘膜屏障机理研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
益生菌Lactobacillus plantarum HNU082在宿主肠道内适应性进化机制研究
- 批准号:32160545
- 批准年份:2021
- 资助金额:36 万元
- 项目类别:地区科学基金项目
相似海外基金
Lactobacillusによる免疫複合体形成が腸管レジリエンス維持に果たす役割
乳酸菌形成免疫复合物在维持肠道弹性中的作用
- 批准号:
23K28020 - 财政年份:2024
- 资助金额:
$ 3.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Highly Acidifying Intravaginal Rings with Lactobacillus Probiotics to Treat Bacterial Vaginosis
含乳酸菌益生菌的高度酸化阴道环可治疗细菌性阴道病
- 批准号:
10699458 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
Role of Lactobacillus-IgG immune complex on functional resilience of gut
乳酸杆菌-IgG 免疫复合物对肠道功能恢复的作用
- 批准号:
23H03330 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Serine-rich repeat proteins in evolution of Lactobacillus-host specificity
乳酸菌宿主特异性进化中富含丝氨酸的重复蛋白
- 批准号:
10573683 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
Regulatory mechanism of intestinal inflammation via promotion of regulatory T cell differentiation by oral administration of Lactobacillus
口服乳酸菌促进调节性T细胞分化调节肠道炎症的机制
- 批准号:
23H02160 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Is Lactobacillus really our friend? -Identification of invasion suppressive Lactobacillus genus in placentation
乳酸菌真的是我们的朋友吗?
- 批准号:
23K15843 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
More Than Mechanical Retention: Characterization of Lactobacillus Clinical Strains Using In Vitro Models
不仅仅是机械保留:使用体外模型表征乳酸菌临床菌株
- 批准号:
10593599 - 财政年份:2023
- 资助金额:
$ 3.57万 - 项目类别:
Quelling UPEC Proliferation by Lactobacillus Mediated Induction of Latent Phages
通过乳酸菌介导的潜伏噬菌体诱导抑制 UPEC 增殖
- 批准号:
10514959 - 财政年份:2022
- 资助金额:
$ 3.57万 - 项目类别:
Mechanistic basis of urinary Lactobacillus enrichment by estrogen hormone therapy
雌激素治疗增加尿乳酸菌的机制基础
- 批准号:
10670681 - 财政年份:2022
- 资助金额:
$ 3.57万 - 项目类别:
Role of probiotic Lactobacillus reuteri in orchestrating systemic anti-tumor immunity
益生菌罗伊氏乳杆菌在协调全身抗肿瘤免疫中的作用
- 批准号:
10586109 - 财政年份:2022
- 资助金额:
$ 3.57万 - 项目类别:














{{item.name}}会员




